As new disease-modifying therapies for Alzheimer’s become available ... and can be applied across PET CT/MRI, MRI, and SPECT imaging modalities, thereby improving patient outcomes." ...

The radiopharmaceutical market has emerged as one of the most significant segments in the healthcare industry, driven by advancements in nuclear medicine and increasing demand for targeted diagnostics ...

Molecular imaging, encompassing both PET and SPECT, provides a noninvasive means to visualize ... parameters that influence ...

This does not of course exclude dementia, nor does it rule out a neurodegenerative cause particularly if the clinical syndrome is mild. If clinical suspicion persists, a SPECT (single photon emission ...

Alzheimer's disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, ...

Unlike existing treatments for Alzheimer’s that target unhealthy protein deposits, the new approach developed at UC San Diego ...

Unlike current practices that depend on positron emission tomography (PET) imaging or lumbar punctures to identify amyloid plaques in the brain—a known marker of Alzheimer’s, the Lumipulse ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease ... functional evaluations, brain imaging, spinal fluid analysis and ...

"The concept of building Alzheimer's Disease focussed diagnostic and treatment clinics that offer a comprehensive package of medical services, including AD screening, brain specific PET scan imaging, ...

Typically, an accurate Alzheimer's diagnosis requires expensive and time-consuming testing, including a brain positron emission tomography (PET) scan, which is a type of imaging test of the brain.

The complete report is contained in Singhal et al, “Dampening of microglial activation with nasal foralumab administration in moderate Alzheimer’s Disease dementia”, Clinical Nuclear ...